Mylan will pay $465M to Medicaid
Drugmaker Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen, ending one of the controversies over the soaring price of the emergency allergy injection.The settlement with the Department of Justice follows news that … Read More


